bortezomib 3.5 MG Injection

RxCUI
402243
RxNorm name
bortezomib 3.5 MG Injection
Display name
bortezomib 3.5 MG Injection
Full name
bortezomib 3.5 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 25 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BortezomibBORTEZOMIBQilu Pharmaceutical Co., Ltd.aef02171-bf8a-43ad-b40c-7642623f98022022-05-09Warnings, Adverse reactionsExact identifier
rxcui: 402243
BORTEZOMIBBORTEZOMIBZydus Lifesciences Limited582c7c0d-fa25-4586-8157-a1e2653d72d92022-05-05Exact identifier
rxcui: 402243
BortezomibBORTEZOMIBPharmascience Inc.191d231a-1fbd-4a65-9d33-d5dc03bac3812022-05-02Warnings, Adverse reactionsExact identifier
rxcui: 402243
BortezomibBORTEZOMIBWaverley Pharma Inca73d7ea7-d068-4d25-b368-fc3db1898be22022-04-13Warnings, Adverse reactionsExact identifier
rxcui: 402243
bortezomibBORTEZOMIBHikma Pharmaceuticals USA Inc.854be921-5fd9-482a-8432-a0c0241625f82021-11-22Warnings, Adverse reactionsExact identifier
rxcui: 402243

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 26 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1521d321-e724-4ffc-adad-34bf4f44fac7bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]236These highlights do not include all the information needed to use VELCADE safely and effectively. See full prescribing information for VELCADE. VELCADE ® (bortezomib) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320250828
664bee24-7af2-2099-ac99-5dd71a1e5a14bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]217These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION . BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320240517
191d231a-1fbd-4a65-9d33-d5dc03bac381bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]28These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320220502
3494c357-a692-4e55-89e1-93532b0baef7bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]27These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320250327
b605b541-4bfd-db3e-9710-11c27f6dee6cbortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]26These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320250916
322e315f-dd94-475f-94f4-4d86a7eb5590bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]26These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320250723
10f60367-0476-4acd-861b-90c18d4b8164bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]25These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320251120
b17ca681-59a5-4af7-98a4-953b38379893bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]23These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB FOR INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 200320251230
3f02670b-5683-780c-9d38-5d8f0ef43a14bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]23These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION . BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320250506
0eb8daef-18da-43bb-b7c6-38c4c8b5dd80bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]23These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320241205
76c7c3a5-fd2f-403f-85fd-65a64538eee7bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]23These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320231020
a73d7ea7-d068-4d25-b368-fc3db1898be2bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]23These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB FOR INJECTION (bortezomib) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320220413
c6b620c6-f3d6-4ff3-b46a-50a66e6d41ddbortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]22These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320250731
41e3de39-8278-4a75-badf-601e4602080dbortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]22These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320240409
b4fb961a-3133-4082-924d-fb2390aafa7ebortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]22These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320231121
d79a71ec-b46d-4961-ad05-8980915cba94bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]22These highlights do not include all the information needed to useBORTEZOMIB FOR INJECTIONsafely and effectively. See full prescribing information forBORTEZOMIB FOR INJECTION. BORTEZOMIBfor injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320231009
854be921-5fd9-482a-8432-a0c0241625f8bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]22These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320211122
decb5d94-2ea2-48d8-b08b-3196b24c0ed3bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320260109
ed526447-a4fe-403b-8f08-21ce1b2fa8b7bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320251223
dc737d3d-2a4e-448a-ad70-e013065c411cbortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320250510
945fbaf0-7a79-4676-aa90-e9a213c0654fbortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320250505
04aafa6a-a50d-4a47-a831-be8e8bb992acbortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320240722
d41340c2-7fe8-42b2-aaa5-c9f9b0e9b50ebortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320220720
12500f21-8e2f-4bcd-861e-4dfca843da2ebortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320220516
aef02171-bf8a-43ad-b40c-7642623f9802bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 200320220509
582c7c0d-fa25-4586-8157-a1e2653d72d9bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD]21BORTEZOMIB for injection, for subcutaneous or intravenous use20220505